vs
Assertio Holdings, Inc.（ASRT）与KKR Real Estate Finance Trust Inc.（KREF）财务数据对比。点击上方公司名可切换其他公司
KKR Real Estate Finance Trust Inc.的季度营收约是Assertio Holdings, Inc.的1.9倍（$25.8M vs $13.5M），KKR Real Estate Finance Trust Inc.同比增速更快（-26.6% vs -57.9%），过去两年KKR Real Estate Finance Trust Inc.的营收复合增速更高（-18.8% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
KKR房地产金融信托公司是全球投资机构KKR旗下的专业房地产金融平台，主要发起、收购并管理优先担保商业地产贷款组合，抵押物多为美国各地的优质机构级商业地产，通过贷款利息收入为投资者提供稳定的经风险调整后的回报。
ASRT vs KREF — 直观对比
营收规模更大
KREF
是对方的1.9倍
$13.5M
营收增速更快
KREF
高出31.3%
-57.9%
两年增速更快
KREF
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $25.8M |
| 净利润 | — | $-26.2M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | -105.1% |
| 净利率 | — | -101.7% |
| 营收同比 | -57.9% | -26.6% |
| 净利润同比 | — | -229.6% |
| 每股收益（稀释后） | $-4.54 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTKREF
| Q4 25 | $13.5M | $25.8M | ||
| Q3 25 | $49.5M | $25.3M | ||
| Q2 25 | $29.2M | $30.2M | ||
| Q1 25 | $26.5M | $31.3M | ||
| Q4 24 | $32.2M | $35.1M | ||
| Q3 24 | $29.2M | $37.0M | ||
| Q2 24 | $31.1M | $40.4M | ||
| Q1 24 | $32.4M | $39.1M |
净利润ASRTKREF
| Q4 25 | — | $-26.2M | ||
| Q3 25 | $11.4M | $13.8M | ||
| Q2 25 | $-16.4M | $-29.7M | ||
| Q1 25 | $-13.5M | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $-2.9M | $-7.4M | ||
| Q2 24 | $-3.7M | $25.8M | ||
| Q1 24 | $-4.5M | $-3.1M |
营业利润率ASRTKREF
| Q4 25 | -86.7% | -105.1% | ||
| Q3 25 | 23.2% | 50.4% | ||
| Q2 25 | -27.5% | -101.3% | ||
| Q1 25 | -50.0% | -18.3% | ||
| Q4 24 | -41.9% | 55.8% | ||
| Q3 24 | -10.4% | -19.6% | ||
| Q2 24 | -11.6% | 63.3% | ||
| Q1 24 | -13.4% | -8.7% |
净利率ASRTKREF
| Q4 25 | — | -101.7% | ||
| Q3 25 | 23.1% | 54.4% | ||
| Q2 25 | -56.0% | -98.5% | ||
| Q1 25 | -51.1% | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | -10.0% | -20.0% | ||
| Q2 24 | -11.8% | 63.9% | ||
| Q1 24 | -13.9% | -7.9% |
每股收益（稀释后）ASRTKREF
| Q4 25 | $-4.54 | $-0.49 | ||
| Q3 25 | $0.11 | $0.12 | ||
| Q2 25 | $-0.17 | $-0.53 | ||
| Q1 25 | $-0.14 | $-0.15 | ||
| Q4 24 | $-3.28 | $0.22 | ||
| Q3 24 | $-0.03 | $-0.19 | ||
| Q2 24 | $-0.04 | $0.29 | ||
| Q1 24 | $-0.05 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $84.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $1.2B |
| 总资产 | $267.0M | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTKREF
| Q4 25 | $63.4M | $84.6M | ||
| Q3 25 | $93.4M | $204.1M | ||
| Q2 25 | $98.2M | $107.7M | ||
| Q1 25 | $87.3M | $106.4M | ||
| Q4 24 | $100.1M | $104.9M | ||
| Q3 24 | $88.6M | $108.8M | ||
| Q2 24 | $88.4M | $107.2M | ||
| Q1 24 | $80.7M | $106.5M |
总债务ASRTKREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTKREF
| Q4 25 | $94.0M | $1.2B | ||
| Q3 25 | $105.8M | $1.2B | ||
| Q2 25 | $93.3M | $1.2B | ||
| Q1 25 | $108.5M | $1.3B | ||
| Q4 24 | $121.1M | $1.3B | ||
| Q3 24 | $130.5M | $1.4B | ||
| Q2 24 | $132.2M | $1.4B | ||
| Q1 24 | $134.5M | $1.4B |
总资产ASRTKREF
| Q4 25 | $267.0M | $6.5B | ||
| Q3 25 | $319.8M | $6.5B | ||
| Q2 25 | $273.8M | $6.8B | ||
| Q1 25 | $286.4M | $6.6B | ||
| Q4 24 | $284.7M | $6.4B | ||
| Q3 24 | $276.0M | $6.8B | ||
| Q2 24 | $279.4M | $7.1B | ||
| Q1 24 | $282.0M | $7.3B |
负债/权益比ASRTKREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $72.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTKREF
| Q4 25 | $-30.0M | $72.3M | ||
| Q3 25 | $-4.8M | $18.5M | ||
| Q2 25 | $19.1M | $21.1M | ||
| Q1 25 | $-12.5M | $15.9M | ||
| Q4 24 | $11.5M | $132.6M | ||
| Q3 24 | $-35.0K | $49.1M | ||
| Q2 24 | $7.4M | $30.6M | ||
| Q1 24 | $7.5M | $34.5M |
资本支出强度ASRTKREF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTKREF
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
KREF
暂无分部数据
